Calfostar

The preparation is administered to animals in the treatment of hypocalcemia and its clinical form – puerperal paresis, in the treatment of rickets, osteodystrophy, puerperal hypophosphatemia, allergic diseases, hypomagnesemia (grass tetany), exudative inflammatory processes, hemorrhages and hemorrhagic diathesis, pre- and postpartum paraplegia, uterine subinvolution.

100 ml of the preparation contains active substances (g):

Calcium gluconate - 32.82;

Calcium glycerophosphate - 8.13;

Magnesium chloride - 4.18.

Excipients: boric acid, water for injections